<SEC-DOCUMENT>0001601830-24-000093-index.html : 20240627 <SEC-HEADER>0001601830-24-000093.hdr.sgml : 20240627 <ACCEPTANCE-DATETIME>20240627130408 ACCESSION NUMBER: 0001601830-24-000093 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-264845 FILM NUMBER: 241077676 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>rxrxfinalprospectussupplem.htm <DESCRIPTION>424B5 <TEXT> Document 1 - file: rxrxfinalprospectussupplem.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>2 <FILENAME>exhibit107-filingfeetable.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 2 - file: exhibit107-filingfeetable.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image_1a.jpg <TEXT> Document 3 - file: image_1a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_2a.jpg <TEXT> Document 4 - file: image_2a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_3a.jpg <TEXT> Document 5 - file: image_3a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_4a.jpg <TEXT> Document 6 - file: image_4a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>recursionlogohorizontalbla.jpg <TEXT> Document 7 - file: recursionlogohorizontalbla.jpg
</DOCUMENT> </SEC-DOCUMENT>